D’autres médecins sont plus inquiets. G., un généraliste qui fait beaucoup de suivis gynécologiques dans le pays de Vannes, estime qu’il a reçu depuis cet été des signalements de troubles menstruels chez « une vaccinée sur deux dans ma patientèle. On n’a jamais vu cela, par exemple des femmes qui saignent pendant des mois, et sur lesquelles on ne trouve pas de polype ou de cancer. »
À la suite de l’appel lancé par Le Télégramme , 39 femmes du pays de Vannes ont décrit leurs troubles menstruels survenus après leurs injections de vaccin contre la Covid. Des perturbations pénibles, voire invalidantes pour certaines, qui restent souvent sans traitement et toujours sans exp...
Thank you very much Dr. Lawrie. Ivermectin interview, Dr. Tess LawrieIvermectin reduces the risk of death from COVID-19 -a rapid review and meta-analysis in ...
02/03/2021
Scientists are looking at a possible link between the mutations in the U.K. and South Africa — and those in a patient in Boston who had living, growing virus in his body for five months.
18/02/2021
Vaccines developed by US companies Pfizer/BioNTech and Moderna are producing fewer antibodies against the coronavirus mutation that has emerged in South Africa, according to studies reported in the New England Journal of Medicine.
17/02/2021
Researchers once believed t would take months or even years for the virus to develop resistance to vaccines. The speedy evolution is largely a result of the virus' unchecked spread.
16/02/2021
Researchers say 32 cases of B1525 in Britain, with other cases in countries including Denmark, US and Australia
15/02/2021
Shops and restaurants could require customers to show vaccine passports under plans being considered by the government, the foreign secretary has suggested.Dominic Raab said that the government was
14/02/2021
Vitamin D!
09/02/2021
Facebook is expanding the list of ‘false’ and ‘debunked’ claims about the coronavirus and vaccines that will be grounds for banning from the platform, while launching the largest ‘authoritative’ vaccination campaign worldwide.
08/02/2021
The EXO-C24 drug has passed Phase 1 trials according to Israeli scientists
03/02/2021
Researchers ‘strongly encouraged’ by findings of reinfection study among UK health workers
03/02/2021
The staff at the Sanger Institute are much more than essential workers -- right now, they're doing some of the most important work on Earth: genetically sequencing the coronavirus. Internally, it's called "Project Heron."
02/02/2021
Controls are being stepped up in parts of the UK hit by new strains of Covid-19, as scientists warned Britain risks becoming a “melting pot” for mutations believed to strengthen the virus’s resistance to vaccines.
Cases in Liverpool and Bristol show variant linked to reduced vaccine efficacy
02/02/2021
Drugs giant raises 2021 profit forecast as many countries scramble to vaccinate their populations.
02/02/2021
Exclusive: no leading contender is effective against all the South African, Brazilian and Kent variants
02/02/2021
Europe chose not to ‘compromise safety and efficacy requirements’, says Ursula von der Leyen
02/02/2021
Mutation known as E484K detected in 11 sequences of British variant, sparking fears virus is further evolving
(Covid-19 Vaccine Side Effects World Map - bit.ly/vaxxmap)
27/12/2020
Parosmia has emerged as a symptom for some long Covid patients
06/12/2020
Former Pfizer Vice President Mike Yeadon discusses his thoughts as to why the lockdown was a mistake, and why the government strategies to manage the pandemic are only making things worse.
24/11/2020
An RNA vaccine or mRNA (messenger RNA) vaccine is a new type of vaccine that inserts fragments of viral mRNA into human cells, which are reprogrammed to produce pathogen antigens (e.g. viral protein spikes or cancer antigens), which then stimulate an adaptive immune response against the pathogen.[1] The mRNA molecule is usually held in a drug delivery vehicle, such as lipid nanoparticles, to protect the fragile mRNA strands, and aid their absorption into the human cells.[2][3] The advantages of RNA vaccines over traditional protein vaccines include production speed and cost,[4][5] and the induction of cellular immunity as well as humoral immunity.[6] The fragility of the mRNA molecule requires cold chain distribution and low temperature storage, and may impair the effective efficacy due to inadequate dosage.[1][4][5]
Up until November 2020, no mRNA vaccine, drug, or technology platform, had ever been approved for use in humans, and before 2020, mRNA was only considered a theoretical or experimental candidate for human use.[1][6][7] As of November 2020, there were two novel mRNA vaccines awaiting emergency use authorization as COVID-19 vaccines (having completed the 8-week required period post final human trials) – MRNA-1273 from Moderna, and BNT162b2 from a BioNTech/Pfizer partnership.[1][7] Global regulators had to balance a lack of medium to longer-term data on potential side-effects from novel mRNA COVID-19 vaccines,[8] with the urgent need to address the global coronavirus pandemic,[7][9] for which the faster production capability of mRNA vaccines is valuable.[10][11]
An RNA vaccine or mRNA (messenger RNA) vaccine is a new type of vaccine for providing acquired immunity through an RNA containing vector, such as lipid nanoparticles.[1]
24/11/2020
New findings from researchers at the Sloan Kettering Institute suggest that cancer causes may be lurking in the molecule that bridges DNA and protein.
Be the first to know and let us send you an email when Coronavirus data posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.
Videos
Doesn't this look like normal flu prevention to you?
Doesn't this look like normal flu prevention to you?
Want your business to be the top-listed Media Company?
Share
Phases of a Pandemic
WHO keeps track of all identified viruses, animal or human, through a set of phases or stages.
Phase 1: Viruses are circulating within animals only. No human infection has resulted from the animal virus.
Phase 2: An animal virus has caused an infection in a human being. At this point, there is a basic level of pandemic threat because the virus strain has mutated to make that transfer to a human.
Phase 3: Small clusters of human beings have contracted the virus in one community. There is potential for the spread of the virus if others outside that community come into contact with those humans who are infected. At this point, the illness may be epidemic in that community, but it is not pandemic.
Phase 4: Human-to-human and animal-to-human virus transmission are causing outbreaks in many communities and more people are getting sick in those communities. More communities report outbreaks and pandemic is more likely, although, according to WHO, a pandemic is not a foregone conclusion.
Phase 5: Human-to-human transmission is taking place in at least two countries in one WHO region. WHO has a network of 120 National Influenza Centers in 90 different countries. At phase 5, most countries are not affected (yet) but a pandemic is considered imminent. This phase is the signal that governments and health officials must be ready to implement their pandemic mitigation plans.
Phase 6: A global pandemic is underway. Illness is widespread and governments and health officials are actively working to curtail the spread of the disease, and help their populations deal with it using preventive and stop-gap measures.
Post-Pandemic: After the increase in activity, the disease-spreading activity will begin to wane. The key at this point is to be prepared to try to prevent a second wave.
The time span for phases 1 through 6 may take place over several months to many years.
